You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (17)

Journals (0)

1-10 of 17 results for axicabtagene ciloleucel

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas

Open access

Review article

First published 2020

Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas

Peter A. Riedell, Michael R. Bishop

Therapeutic Advances in Hematology

Select article: Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States

Open access

Research article

First published 2023

Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States

Na Li, Jianying Lei, Jiahao Zhang [...]

Therapeutic Advances in Hematology

Select article: Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-cell Therapy in Relapsed and Refractory Large B-cell Lymphoma

Retricted access

Review article

First published 2021-3

Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-cell Therapy in Relapsed and Refractory Large B-cell Lymphoma

Zachery Halford, Mary Kate Anderson, Lunawati L. Bennett

Annals of Pharmacotherapy

Select article: The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma

Open access

Review article

First published 2021

The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma

Jose Sandoval-Sus, Julio C. Chavez

Therapeutic Advances in Hematology

Select article: Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median

Open access

Letter

First published 2020

Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median

Andrea Messori, Marco Chiumente, Daniele Mengato

Therapeutic Advances in Medical Oncology

Select article: Chimeric antigen receptor T-cell therapy: Foundational science and clinical knowledge for pharmacy practice

Retricted access

Review article

First published 2019-7

Chimeric antigen receptor T-cell therapy: Foundational science and clinical knowledge for pharmacy practice

Anna Dushenkov, Paiboon Jungsuwadee

Journal of Oncology Pharmacy Practice

Select article: A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States

Open access

Research article

First published 2025-1

A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States

Anik R. Patel, Bradley Kievit, Ken Hasegawa [...]

MDM Policy & Practice

Select article: Efficacy and safety of chimeric antigen receptor T-cell therapy in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis

Open access

Research article

First published 2026

Efficacy and safety of chimeric antigen receptor T-cell therapy in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis

Qiang Li, Shenghua Xu, Yun Zhong [...]

Therapeutic Advances in Hematology

Select article: Understanding the differences in outcome between CART studies as second-line treatment in aggressive lymphoma

Retricted access

Review article

First published 2023-1

Understanding the differences in outcome between CART studies as second-line treatment in aggressive lymphoma

Reyad Dada

Journal of Oncology Pharmacy Practice

Select article: New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Retricted access

Review article

First published 2022-12

New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Donald C. Moore, Matthew R. Peery, Katherine A. Tobon [...]

Journal of Oncology Pharmacy Practice

1
2
10 / page

Article type

Publication date

Subjects

Access